Document:

THIS NOTE AND THE
OBLIGATIONS EVIDENCED HEREBY ARE SUBORDINATE IN THE MANNER AND TO THE EXTENT SET FORTH IN THAT CERTAIN SUBORDINATION AND INTERCREDITOR
AGREEMENT, DATED AS OF JUNE 28, 2013 (THE “SUBORDINATION AGREEMENT”), AMONG LKL INVESTMENTS, LLC, ALOSTAR BANK
OF COMMERCE, LAKELAND INDUSTRIES, INC. (“LAKELAND US”), AND LAKELAND PROTECTIVE WEAR INC. (“LAKELAND
CANADA”, TOGETHER WITH LAKELAND US, COLLECTIVELY, THE “BORROWERS”) TO THE INDEBTEDNESS OWED BY THE
BORROWERS PURSUANT TO THAT CERTAIN LOAN AND SECURITY AGREEMENT, DATED AS OF JUNE 28, 2013, AMONG ALOSTAR BANK OF COMMERCE AND THE
BORROWERS; AND EACH HOLDER OF THIS INSTRUMENT, BY ITS ACCEPTANCE HEREOF, IRREVOCABLY AGREES TO BE BOUND BY THE PROVISIONS OF THE
SUBORDINATION AGREEMENT.

 

TERM NOTE

 

	U.S. $3,500,000	June 28, 2013
	 	New York, New York

 

FOR VALUE RECEIVED,
the undersigned, LAKELAND INDUSTRIES, INC., a Delaware corporation (“Lakeland US”), and LAKELAND PROTECTIVE
WEAR INC., a Canadian corporation (“Lakeland Canada”; Lakeland US and Lakeland Canada are sometimes referred
to herein individually as a “Borrower” and collectively as “Borrowers”), hereby jointly and
severally promise to pay to the order of LKL INVESTMENTS, LLC (herein, together with any subsequent holder hereof, called
“Lender”), the principal sum of THREE MILLION, FIVE HUNDRED THOUSAND AND NO/100 DOLLARS ($3,500,000) on
the date on which such outstanding principal amounts become due and payable pursuant to Section 2.2(a)(i) of the Term Loan
Agreement (as defined below), in strict accordance with the terms thereof. Borrowers, jointly and severally, likewise unconditionally
promise to pay to Lender interest from and after the date hereof on the outstanding principal amount hereof at such interest rates,
payable at such times and computed in such manner as are specified in Sections 2.2(a)(ii) and 2.3 of the Term Loan
Agreement and in strict accordance with the terms thereof.

 

This Term Note (this
“Note”) is issued pursuant to, and is the “Term Note” referred to in, the Term Loan and Security
Agreement dated as of June 28, 2013 (as the same may be amended, restated, supplemented or otherwise modified from time to time,
the “Term Loan Agreement”), among Borrowers and Lender, and Lender is and shall be entitled to all benefits
thereof and of all other Term Loan Documents executed and delivered in connection therewith. All capitalized terms used herein,
unless otherwise defined herein, shall have the meanings ascribed to such terms under the Term Loan Agreement.

 

The entire unpaid principal
balance and all accrued interest on this Note shall be due and payable immediately upon the Maturity Date. All payments of
principal and interest shall be made in Dollars and in immediately available funds as specified in the Term Loan Agreement.

 

    	 

    	 

    

 

Upon or after the occurrence
of an Event of Default and for so long as such Event of Default exists, the principal balance and all accrued interest of this
Note may be declared (or shall become) due and payable in the manner and with the effect provided in the Term Loan Agreement, and
the unpaid principal balance hereof shall bear interest at the Default Rate as and when provided in Section 2.3 of the Term
Loan Agreement. If this Note is collected by or through an attorney at law, then Borrowers, jointly and severally, shall be obligated
to pay, in addition to the principal balance of and accrued interest on this Note, all costs of collection, including, without
limitation, reasonable attorneys’ fees and court costs.

 

The principal amount
of this Note, and all accrued and unpaid interest thereon, shall be deemed evidenced by this Note and shall continue to be owing
by Borrowers until paid in accordance with the terms of this Note and the Term Loan Agreement.

 

In no contingency or
event whatsoever shall the amount paid or agreed to be paid to Lender for the use, forbearance or detention of credit hereunder
exceed the highest lawful rate permissible under any law which a court of competent jurisdiction may deem applicable hereto; and,
in the event of any such payment inadvertently paid by Borrowers or inadvertently received by Lender, such excess sum shall be,
at Borrowers’ option, returned to Borrowers forthwith or credited as a payment of principal, but shall not be applied to
the payment of interest. It is the intent hereof that Borrowers not pay or contract to pay, and that Lender not receive or
contract to receive, directly or indirectly in any manner whatsoever, interest in excess of that which may be paid by Borrowers
under applicable law.

 

Time is of the essence
of this Note. To the fullest extent permitted by applicable law, each Borrower, for itself and its legal representatives, successors
and assigns, expressly waives presentment, demand, protest, notice of dishonor, notice of non-payment, notice of maturity, notice
of protest, presentment for the purpose of accelerating maturity, diligence in collection, and the benefit of any exemption or
insolvency laws.

 

Wherever possible each
provision of this Note shall be interpreted in such a manner as to be effective and valid under applicable law, but if any provision
of this Note shall be prohibited or invalid under applicable law, such provision shall be ineffective to the extent of such prohibition
or invalidity without invalidating the remainder of such provision or remaining provisions of this Note. No delay or failure on
the part of Lender in the exercise of any right or remedy hereunder shall operate as a waiver thereof, nor as an acquiescence in
any default, nor shall any single or partial exercise by Lender of any right or remedy preclude any other right or remedy. Lender,
at its option, may enforce its rights against any Collateral securing this Note without enforcing its rights against any Borrower,
any Guarantor of the indebtedness evidenced hereby or any other property or indebtedness due or to become due to any Borrower.
Each Borrower agrees that, without releasing or impairing such Borrower’s liability hereunder, Lender may at any time release,
surrender, substitute or exchange any Collateral securing this Note and may at any time release any party primarily or secondarily
liable for the indebtedness evidenced by this Note.

 

The rights of Lender
and obligations of Borrowers hereunder shall be construed in accordance with and governed by the laws (without giving effect to
the conflict of law principles thereof) of the State of New York. This Note is executed and delivered in, and the amount of the
loan evidenced by this Note is advanced in, the State of New York.

 

    	- 2 -

    	 

    

 

To the fullest extent
permitted by applicable law, each Borrower and, by its acceptance hereof, Lender, each hereby waives the right to trial by jury
in any action, suit, proceeding or counterclaim of any kind arising out of, related to or based in any way upon this Note or any
of the matters contemplated hereby.

 

[Remainder of page intentionally
left blank]

 

    	- 3 -

    	 

    

 

IN WITNESS WHEREOF,
each Borrower has caused this Note to be executed and delivered by its duly authorized officer on the date first above written.

 

	 	BORROWERS:
	 	 
	 	LAKELAND INDUSTRIES, INC.
	 	 
	 	By:	/s/ Christopher J. Ryan
	 	Name:	Christopher J. Ryan
	 	Title:	President and Chief Executive Officer
	 	 
	 	LAKELAND PROTECTIVE WEAR INC.
	 	 
	 	By:	/s/ Christopher J. Ryan
	 	Name:	Christopher J. Ryan
	 	Title:	Assistant Secretary

 

    	- 4 -THE
SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION
OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND, ACCORDINGLY, MAY
NOT BE TRANSFERRED UNLESS (I) SUCH SECURITIES HAVE BEEN REGISTERED FOR SALE PURSUANT TO THE SECURITIES ACT OF 1933, AS AMENDED,
(II) SUCH SECURITIES MAY BE SOLD PURSUANT TO RULE 144 OR (III) THE COMPANY HAS RECEIVED AN OPINION OF COUNSEL, REASONABLY
SATISFACTORY TO IT, THAT SUCH TRANSFER MAY LAWFULLY BE MADE WITHOUT REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED.

 

PURSUANT
TO THE TERMS OF SECTION 1 OF THIS WARRANT, ALL OR A PORTION OF THIS WARRANT MAY HAVE BEEN EXERCISED, AND THEREFORE THE ACTUAL NUMBER
OF WARRANT SHARES REPRESENTED BY THIS WARRANT MAY BE LESS THAN THE AMOUNT SET FORTH ON THE FACE HEREOF.

 

lAKELAND
iNDUSTRIES, iNC.

 

Warrant
To Purchase Common Stock

 

Warrant No.: 2013-1

Number of Shares of Common Stock: 566,015

Date of Issuance: June 28, 2013 (“Issuance
Date”)

 

Lakeland Industries,
Inc., a Delaware corporation (the “Company”), hereby certifies that, for good and valuable consideration, the
receipt and sufficiency of which are hereby acknowledged, LKL INVESTMENTS, LLC, the registered holder hereof or its assigns (the
“Holder”), is entitled, subject to the terms set forth below, to purchase from the Company, at the Exercise
Price then in effect, upon surrender of this Warrant to Purchase Common Stock (including any Warrants to Purchase Common Stock
issued in exchange, transfer or replacement hereof, the “Warrant”), at any time or times on or after the Issuance
Date, but not after 11:59 p.m., New York time, on the Expiration Date, Five Hundred Sixty-Six Thousand Fifteen (566,015) duly
authorized, validly issued, fully paid and nonassessable shares of Common Stock (as adjusted from time to time as provided herein,
the “Warrant Shares”). Except as otherwise defined herein, capitalized terms in this Warrant shall have the
meanings set forth in Section 16. This Warrant is issued pursuant to the Loan and Security Agreement (as it may be
amended, restated, supplemented or otherwise modified from time to time, the “Financing Agreement”), dated as
of June 28, 2013 (the “Subscription Date”), by and among the Company, Lakeland Protective Wear Inc. and
the investor(s) party thereto. This Warrant, together with any other warrants containing substantially identical terms and conditions
issued pursuant to or in connection with the Financing Agreement, are collectively referred to herein as the “Warrants”.

 

    	 

    	 

    

 

		1.	EXERCISE OF WARRANT.

 

(a)  Mechanics
of Exercise. Subject to the terms and conditions hereof, this Warrant may be exercised by the Holder on any day on or after
the Issuance Date, in whole or in part, by (i) delivery of a written notice, in the form attached hereto as Exhibit A
(the “Exercise Notice”), of the Holder’s election to exercise this Warrant and (ii)(A) payment to
the Company of an amount equal to the applicable Exercise Price multiplied by the number of Warrant Shares as to which this Warrant
is being exercised (the “Aggregate Exercise Price”) in cash or wire transfer of immediately available funds
(a “Cash Exercise”) or (B) notifying the Company that this Warrant is being exercised pursuant to a Cashless
Exercise (as defined in Section 1(d)) (the items under clause (i) and (ii)(A) or (B) above, as applicable, the
“Exercise Delivery Documents”). The Holder shall not be required to surrender this Warrant in order to effect
an exercise hereunder; provided, however, that in the event that this Warrant is exercised in full or for the remaining
unexercised portion hereof, the Holder shall deliver this Warrant to the Company for cancellation within a reasonable time after
such exercise. On or before the first Trading Day following the date on which the Company has received the applicable Exercise
Delivery Documents (the date upon which the Company has received all of the applicable Exercise Delivery Documents, the “Exercise
Date”), the Company shall transmit by facsimile or e-mail transmission an acknowledgment of confirmation of receipt of
the Exercise Delivery Documents to the Holder and the Company’s transfer agent for the Common Stock (the “Transfer
Agent”). The Company shall deliver any objection to the Exercise Delivery Documents on or before the second Trading Day
following the date on which the Company has received all of the applicable Exercise Delivery Documents. On or before the second
Trading Day following the date on which the Company has received all of the applicable Exercise Delivery Documents (the “Share
Delivery Date”), the Company shall, (X) provided that the Transfer Agent is participating in The Depository
Trust Company (“DTC”) Fast Automated Securities Transfer Program (the “FAST Program”), upon
the request of the Holder, credit such aggregate number of Warrant Shares to which the Holder is entitled pursuant to such exercise
to the Holder’s or its designee’s balance account with DTC through its Deposit Withdrawal Agent Commission system or
(Y) if the Transfer Agent is not participating in the FAST Program, issue and dispatch by overnight courier to the address
as specified in the Exercise Notice, a certificate, registered in the Company’s share register in the name of the Holder
or its designee, for the number of Warrant Shares to which the Holder is entitled pursuant to such exercise. Upon delivery of the
applicable Exercise Delivery Documents, the Holder shall be deemed for all corporate purposes to have become the holder of record
of the Warrant Shares with respect to which this Warrant has been exercised, irrespective of the date such Warrant Shares are credited
to the Holder’s DTC account or the date of delivery of the certificates evidencing such Warrant Shares, as the case may be.
If this Warrant is submitted in connection with any exercise pursuant to this Section 1(a) and the number of Warrant
Shares represented by this Warrant submitted for exercise is greater than the number of Warrant Shares being acquired upon an exercise,
then the Company shall as soon as practicable and in no event later than three Trading Days after any such submission and at its
own expense, issue a new Warrant (in accordance with Section 7(d)) representing the right to purchase the number of
Warrant Shares purchasable immediately prior to such exercise under this Warrant, less the number of Warrant Shares with respect
to which this Warrant has been and/or is exercised. No fractional Warrant Shares are to be issued upon the exercise of this Warrant,
but rather the number of Warrant Shares to be issued shall be rounded up to the nearest whole number. The Company shall pay any
and all taxes and other expenses (including overnight delivery charges) that may be payable with respect to the issuance and delivery
of Warrant Shares upon exercise of this Warrant; provided, however, that the Company shall not be required to pay
any tax which may be payable in respect of any transfer involved in the registration of any certificates for Warrant Shares or
Warrants in a name other than that of the Holder or an affiliate thereof nor any income, capital gain or similar income-based taxes
payable by the Holder.

 

    	2

    	 

    

 

(b) Exercise
Price. For purposes of this Warrant, “Exercise Price” means $0.01, subject to adjustment as provided herein.

 

(c) Company’s
Failure to Timely Deliver Securities. If the Company shall fail for any reason or for no reason to issue to the Holder within
three (3) Trading Days of the Exercise Date a certificate for the number of Warrant Shares to which the Holder is entitled and
register such Warrant Shares on the Company’s share register or to credit the Holder’s or its designee’s balance
account with DTC for such number of Warrant Shares to which the Holder is entitled upon the Holder’s exercise of this Warrant,
and if on or after such Trading Day the Holder purchases, or another Person purchases on the Holder’s behalf or for the Holder’s
account (in an open market transaction or otherwise) shares of Common Stock to deliver in satisfaction of a sale by the Holder
of Warrant Shares issuable upon such exercise that the Holder anticipated receiving from the Company (a “Buy-In”),
then the Company shall, within three (3) Trading Days after the Holder’s written request and in the Holder’s discretion,
either (i) pay cash to the Holder in an amount equal to the Holder’s total purchase price (including brokerage commissions,
if any) for the shares of Common Stock so purchased (the “Buy-In Price”), at which point the Company’s
obligation to deliver such certificate (and to issue such Warrant Shares) shall terminate (and such Warrant Shares shall be deducted
from the number of Warrant Shares issuable pursuant to this Warrant), or (ii) promptly honor its obligation to deliver to the Holder
a certificate or certificates representing such Warrant Shares and pay cash to the Holder in an amount equal to the excess (if
any) of the Buy-In Price over the product of (A) such number of Warrant Shares, times (B) the Closing Bid Price on the
date of exercise (or, if higher, the actual price per share obtained by the Holder in the sale for which a Buy-In was necessitated).
Nothing herein shall limit the Holder’s right to pursue damages for the Company’s failure to maintain a sufficient
number of authorized shares of Common Stock or to otherwise issue shares of Common Stock upon exercise of this Warrant in accordance
with the terms hereof, and the Holder shall have the right to pursue all remedies available at law or in equity (including a decree
of specific performance and/or injunctive relief).

 

(d) Cashless
Exercise. Notwithstanding anything contained herein to the contrary, the Holder may, in its sole discretion, exercise this
Warrant in whole or in part and, in lieu of making the cash payment otherwise contemplated to be made to the Company upon such
exercise in payment of the Aggregate Exercise Price, elect instead to receive upon such exercise the “Net Number”
of Warrant Shares determined according to the following formula (a “Cashless Exercise”):

 

    	3

    	 

    

 

Net Number = (A x B) - (A x C)

B

 

For purposes of the foregoing formula:

 

A= the
total number of Warrant Shares with respect to which this Warrant is then being exercised.

 

B= the
arithmetic average of the Closing Sale Prices of the shares of Common Stock for the five (5) consecutive Trading Days ending on
the date immediately preceding the date of the Exercise Notice.

 

C= the
Exercise Price then in effect for the applicable Warrant Shares at the time of such exercise.

 

(e) Rule 144.
For purposes of Rule 144(d) promulgated under the Securities Act, as in effect on the date hereof, assuming the Holder is not an
affiliate of the Company, it is intended that the Warrant Shares issued in a Cashless Exercise shall be deemed to have been acquired
by the Holder, and the holding period for the Warrant Shares shall be deemed to have commenced, on the date this Warrant was originally
issued to the Holder.

 

(f) Disputes.
In the case of a dispute as to the determination of the Exercise Price or the arithmetic calculation of the Warrant Shares, the
Company shall promptly issue to the Holder the number of Warrant Shares that are not disputed.

 

2.  ADJUSTMENT
OF EXERCISE PRICE AND NUMBER OF WARRANT SHARES. The Exercise Price and the number of Warrant Shares shall be adjusted from
time to time as follows:

 

(a) Adjustment
upon Issuance of shares of Common Stock. If and whenever on or after the Subscription Date, the Company issues or sells,
or in accordance with this Section 2 is deemed to have issued or sold, any shares of Common Stock (including the issuance
or sale of shares of Common Stock owned or held by or for the account of the Company, but excluding shares of Common Stock deemed
to have been issued by the Company in connection with any Excluded Securities) (the “Additional Shares”) for
a consideration per share (the “New Issuance Price”) less than a price (the “Applicable Price”)
equal to the Reference Price in effect immediately prior to such issuance or sale or deemed issuance or sale (the foregoing a “Dilutive
Issuance”), then immediately after each such Dilutive Issuance, the number of Warrant Shares issuable upon the exercise
of this Warrant shall be increased to a number determined by multiplying the previously applicable number of Warrant Shares issuable
upon the exercise of this Warrant by a fraction, (i) the numerator of which shall be the sum of (A) the
number of shares of Common Stock outstanding immediately prior to such issuance or sale, or deemed issuance or sale, plus
(B) the number of Additional Shares issued or sold or deemed to be issued or sold and (ii) the denominator of
which shall be the sum of (x) the number of shares of Common Stock outstanding immediately prior to such issuance or
sale, or deemed issuance or sale, plus (y) the number of shares of Common Stock that the aggregate consideration received
by the Company for the Additional Shares so issued or sold or deemed to be issued or sold would purchase at the Reference Price
per share of Common Stock in effect immediately prior to such issuance or sale, or deemed issuance or sale.

 

    	4

    	 

    

 

For purposes of determining
the adjusted number of Warrant Shares under this Section 2(a), the following shall be applicable:

 

(i) Issuance
of Options. If the Company in any manner grants or sells any Options and the lowest price per share for which one share of
Common Stock is issuable upon the exercise of any such Option or upon conversion, exercise or exchange of any Convertible Securities
issuable upon exercise of any such Option is less than the Applicable Price, then such share of Common Stock shall be deemed to
be outstanding and to have been issued and sold by the Company at the time of the granting or sale of such Option for such price
per share. For purposes of this Section 2(a)(i), the “lowest price per share for which one share of Common Stock
is issuable upon exercise of any such Option or upon conversion, exercise or exchange of any Convertible Securities issuable upon
exercise of any such Option” shall be equal to the sum of the lowest amounts of consideration (if any) received or receivable
by the Company with respect to any one share of Common Stock upon the granting or sale of the Option, upon exercise of the Option
and upon conversion, exercise or exchange of any Convertible Security issuable upon exercise of such Option less any consideration
paid or payable by the Company with respect to such one share of Common Stock upon the granting or sale of such Option, upon exercise
of such Option and upon conversion, exercise or exchange of any Convertible Security issuable upon exercise of such Option. No
further adjustment of the number of Warrant Shares shall be made upon the actual issuance of such shares of Common Stock or of
such Convertible Securities upon the exercise of such Options or upon the actual issuance of such shares of Common Stock upon conversion,
exercise or exchange of such Convertible Securities.

 

(ii) Issuance
of Convertible Securities. If the Company in any manner issues or sells any Convertible Securities and the lowest price per
share for which one share of Common Stock is issuable upon the conversion, exercise or exchange thereof is less than the Applicable
Price, then such share of Common Stock shall be deemed to be outstanding and to have been issued and sold by the Company at the
time of the issuance or sale of such Convertible Securities for such price per share. For the purposes of this Section 2(a)(ii),
the “lowest price per share for which one share of Common Stock is issuable upon the conversion, exercise or exchange thereof”
shall be equal to the sum of the lowest amounts of consideration (if any) received or receivable by the Company with respect to
one share of Common Stock upon the issuance or sale of the Convertible Security and upon conversion, exercise or exchange of such
Convertible Security less any consideration paid or payable by the Company with respect to such one share of Common Stock upon
the issuance or sale of such Convertible Security and upon conversion, exercise or exchange of such Convertible Security. No further
adjustment of the number of Warrant Shares shall be made upon the actual issuance of such shares of Common Stock upon conversion,
exercise or exchange of such Convertible Securities, and if any such issue or sale of such Convertible Securities is made upon
exercise of any Options for which adjustment of this Warrant has been or is to be made pursuant to other provisions of this Section 2(a),
no further adjustment of the number of Warrant Shares shall be made by reason of such issue or sale.

 

    	5

    	 

    

 

(iii) Change
in Option Price or Rate of Conversion; Expiration.

 

(A)    If
the purchase price provided for in any Options, the additional consideration, if any, payable upon the issue, conversion, exercise
or exchange of any Convertible Securities, or the rate at which any Convertible Securities are convertible into or exercisable
or exchangeable for shares of Common Stock increases or decreases at any time, the number of Warrant Shares in effect at the time
of such increase or decrease shall be adjusted to the number of Warrant Shares which would have been in effect at such time had
such Options or Convertible Securities provided for such increased or decreased purchase price, additional consideration or increased
or decreased conversion rate, as the case may be, at the time initially granted, issued or sold. For purposes of this Section 2(a)(iii)(A),
if the terms of any Option or Convertible Security that was outstanding as of the date of issuance of this Warrant are increased
or decreased in the manner described in the immediately preceding sentence, then such Option or Convertible Security and the shares
of Common Stock deemed issuable upon exercise, conversion or exchange thereof shall be deemed to have been issued as of the date
of such increase or decrease. No adjustment pursuant to this Section 2(a) shall be made if such adjustment would result
in a decrease in the number of Warrant Shares.

 

(B)    In
the event of the expiration of an unexercised Option or non-converted Convertible Security, any previous adjustment of the Exercise
Price and number of Warrant Shares in respect thereof pursuant to this Section 2(a) shall be readjusted to such Exercise
Price and number of Warrant Shares as would have been obtained had such Option or Convertible Security never been issued.

 

(iv) Calculation
of Consideration Received. In case any Options are issued in connection with the issue or sale of other securities of the Company,
together comprising one integrated transaction in which no specific consideration is allocated to such Options by the parties thereto,
the Options will be deemed to have been issued for a consideration of $0.01. If any shares of Common Stock, Options or Convertible
Securities are issued or sold or deemed to have been issued or sold for cash, the consideration received therefor will be deemed
to be the net amount received by the Company therefor. If any shares of Common Stock, Options or Convertible Securities are issued
or sold for a consideration other than cash, the amount of such consideration received by the Company will be the fair value of
such consideration, except where such consideration consists of securities, in which case the amount of consideration received
by the Company will be the Closing Sale Price of such security on the date of receipt. If any shares of Common Stock, Options or
Convertible Securities are issued to the owners of the non-surviving entity in connection with any merger in which the Company
is the surviving entity, the amount of consideration therefor will be deemed to be the fair value of such portion of the net assets
and business of the non-surviving entity as is attributable to such shares of Common Stock, Options or Convertible Securities,
as the case may be. The fair value of any consideration other than cash or securities will be determined jointly by the Company
and the Required Holders. If such parties are unable to reach agreement within ten (10) days after the occurrence of an event requiring
valuation (the “Valuation Event”), the fair value of such consideration will be determined within five (5) Trading
Days after the tenth (10th) day following the Valuation Event by an independent, reputable appraiser jointly selected by the Company
and the Required Holders. The determination of such appraiser shall be final and binding upon all parties absent manifest error
and the fees and expenses of such appraiser shall be borne by the Company.

 

    	6

    	 

    

 

(v) Record
Date. If the Company takes a record of the holders of shares of Common Stock for the purpose of entitling them (A) to receive
a dividend or other distribution payable in shares of Common Stock, Options or in Convertible Securities or (B) to subscribe for
or purchase shares of Common Stock, Options or Convertible Securities, then such record date will be deemed to be the date of the
issue or sale of the shares of Common Stock deemed to have been issued or sold upon the declaration of such dividend or the making
of such other distribution or the date of the granting of such right of subscription or purchase, as the case may be.

 

(vi) Principal
Market Limitation. Notwithstanding any other provision to the contrary in this Warrant (including this Section 2(a)),
if a reduction in the Exercise Price or increase in the number of Warrant Shares issuable upon the exercise of this Warrant pursuant
to the terms of this Warrant (other than as set forth in this clause (a)(vi)) or the issuance of any shares of Common
Stock (“Interest Shares”) as payment of interest or other amounts in respect of the debt incurred under the
Financing Agreement or other Transaction Agreements (“Debt Obligations”) would require the Company to obtain
stockholder approval of the offering contemplated by the Transaction Documents pursuant to Nasdaq Marketplace Rule 5635 or
other applicable rules or regulations of the Principal Market and such stockholder approval has not been obtained, (A) the
Exercise Price shall be reduced to the maximum extent that would not require such stockholder approval thereunder, (B) the
number of Warrant Shares issuable upon the exercise of this Warrant shall be increased to the maximum extent that would not require
such stockholder approval thereunder and (C) the Company shall not be entitled or obligated to
pay Debt Obligations in Interest Shares.

 

    	7

    	 

    

 

In order
to comply with the rules and regulations of the Principal Market, and regardless of whether or not the Common Stock is traded on
the Principal Market, the Company shall not issue any shares of Common Stock upon exercise of this Warrant
if the issuance of such shares of Common Stock would, when added to the aggregate number of shares of Common Stock previously
issued upon the exercise of the Warrants and as Interest Shares pursuant to the Financing Agreement, exceed in the aggregate 1,068,506
shares of Common Stock (appropriately adjusted for any stock split, reverse stock split, stock dividend or other reclassification
or combination of the Common Stock occurring after the Subscription Date) (the “Exchange Cap”). Until such stockholder
approval is obtained, no purchaser of the Warrants pursuant to the Financing Agreement (the “Purchasers”) shall
be issued in the aggregate, upon exercise of Warrants or as payment of Interest Shares, shares of Common Stock in an amount greater
than the product of the Exchange Cap multiplied by a fraction, (x) the numerator of which is the number of shares of
Common Stock underlying the Warrants issued to it pursuant to the Financing Agreement on the Subscription Date and (y) the
denominator of which is the aggregate number of shares of Common Stock underlying the Warrants issued to the Purchasers
pursuant to the Financing Agreement on the Subscription Date (with respect to each Purchaser, the “Exchange Cap
Allocation”). In the event that any Purchaser shall sell or otherwise transfer any of such Purchaser’s Warrants,
the transferee, if a registered Holder of such Warrants, shall be allocated a pro rata portion of such Purchaser’s Exchange
Cap Allocation, and the restrictions of the prior sentence shall apply to such transferee with respect to the portion of the Exchange
Cap Allocation allocated to such transferee. In the event that any holder of Warrants shall exercise all of such holder’s
Warrants into a number of shares of Common Stock which, in the aggregate, is less than such holder's Exchange Cap Allocation, then
the difference between such holder’s Exchange Cap Allocation and the number of shares of Common Stock actually issued to
such holder shall be allocated to the respective Exchange Cap Allocations of the remaining registered holders of Warrants on a
pro rata basis in proportion to the aggregate number of shares of Common
Stock underlying the Warrants then held by each such holder. To the extent required by the Principal Market, the provisions
of the Exchange Cap shall be modified to comply with the applicable rules and regulations of the Principal Market, provided
that any such changes shall not, in the Holder’s reasonable discretion, materially change the terms of the transactions contemplated
hereby.

 

(b) Voluntary
Adjustment By Company. The Company may at any time during the term of this Warrant reduce the then current Exercise Price to
any amount and for any period of time deemed appropriate by the Board of Directors of the Company.

 

(c) Adjustment
upon Subdivision or Combination of Common Stock. If the Company at any time on or after the Subscription Date subdivides
(by any stock split, stock dividend, recapitalization, reorganization, scheme, arrangement or otherwise) one or more classes of
its outstanding shares of Common Stock into a greater number of shares, the Exercise Price in effect immediately prior to such
subdivision will be proportionately reduced and the number of Warrant Shares will be proportionately increased. If the Company
at any time on or after the Subscription Date combines (by any stock split, stock dividend, recapitalization, reorganization, scheme,
arrangement or otherwise) one or more classes of its outstanding shares of Common Stock into a smaller number of shares, the Exercise
Price in effect immediately prior to such combination will be proportionately increased and the number of Warrant Shares will be
proportionately decreased. Any adjustment under this Section 2(c) shall become effective at the close of business on
the date the subdivision or combination becomes effective.

 

(d) Other Events.
If any event occurs of the type contemplated by the provisions of this Section 2 but not expressly provided for by
such provisions (including, without limitation, the granting of stock appreciation rights, phantom stock rights or other rights
with equity features), then the Company’s Board of Directors will make an appropriate adjustment in the Exercise Price and
the number of Warrant Shares so as to protect the rights of the Holder; provided that no such adjustment pursuant to this
Section 2(d) will increase the Exercise Price or decrease the number of Warrant Shares as otherwise determined pursuant
to this Section 2.

 

    	8

    	 

    

 

(e) Par Value
Minimum. Notwithstanding any other provision of this Warrant (including the foregoing provisions of this Section 2)
to the contrary, the Exercise Price shall not be adjusted below the par value of a share of Common Stock.

 

3.  RIGHTS
UPON DISTRIBUTION OF ASSETS. If the Company shall, at any time after the issuance of this Warrant, declare or make any dividend
or other distribution of evidences of indebtedness or assets (including cash and cash dividends) or rights or warrants to subscribe
for or purchase any security to holders of shares of Common Stock (including, without limitation, any distribution of cash, stock
or other securities not addressed by Section 2, or property or options not addressed by Section 2, by way
of a dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a “Distribution”),
then, in each such case:

 

(a)      any
Exercise Price in effect immediately prior to the close of business on the record date fixed for the determination of holders of
shares of Common Stock entitled to receive the Distribution shall be reduced, effective as of the close of business on such record
date, to a price determined by multiplying such Exercise Price by a fraction of which (i) the numerator shall be the
Closing Bid Price of a share of Common Stock on the Trading Day immediately preceding such record date minus the value of
the Distribution (as determined in good faith by the Company’s Board of Directors) applicable to one share of Common Stock
and (ii) the denominator shall be the Closing Bid Price of a share of Common Stock on the Trading Day immediately preceding
such record date; and

 

(b)      the
number of Warrant Shares issuable upon the exercise of this Warrant shall be increased to a number of shares equal to the number
of shares of Common Stock obtainable immediately prior to the close of business on the record date fixed for the determination
of holders of shares of Common Stock entitled to receive the Distribution multiplied by the reciprocal of the fraction set
forth in the immediately preceding paragraph (a); provided that in the event that the Distribution is of shares
of Common Stock (or common stock) (“Other Shares of Common Stock”) of a company whose common shares are traded
on a national securities exchange or a national automated quotation system, then the Holder may elect to receive a warrant to purchase
Other Shares of Common Stock in lieu of an increase in the number of Warrant Shares, the terms of which shall be identical to those
of this Warrant, except that such warrant shall be exercisable into the number of Other Shares of Common Stock that would have
been payable to the Holder pursuant to the Distribution had the Holder exercised this Warrant immediately prior to such record
date and with an aggregate exercise price equal to the product of the amount by which the exercise price of this Warrant was decreased
with respect to the Distribution pursuant to the terms of the immediately preceding paragraph (a) and the number of
Warrant Shares calculated in accordance with the first part of this paragraph (b).

 

		4.	PURCHASE RIGHTS; FUNDAMENTAL TRANSACTIONS.

 

(a) Purchase
Rights. In addition to any adjustments pursuant to Section 2 above, if at any time the Company grants, issues or
sells any Options, Convertible Securities or rights to purchase stock, warrants, securities or other property pro rata to the record
holders of any class of Common Stock (the “Purchase Rights”), then the Holder will be entitled to acquire, upon
the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder
had held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations
on the exercise of this Warrant) immediately before the date on which a record is taken for the grant, issuance or sale of such
Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are to be determined
for the grant, issue or sale of such Purchase Rights.

 

    	9

    	 

    

 

(b) Fundamental
Transactions. Upon the occurrence of any Fundamental Transaction, the Successor Entity shall succeed to, and be substituted
for (so that from and after the date of such Fundamental Transaction, the provisions of this Warrant referring to the “Company”
shall refer instead to the Successor Entity), and may exercise every right and power of the Company and shall assume all of the
obligations of the Company under this Warrant with the same effect as if such Successor Entity had been named as the Company herein.
Upon consummation of the Fundamental Transaction, the Successor Entity shall deliver to the Holder confirmation that there shall
be issued upon exercise of this Warrant at any time after the consummation of the Fundamental Transaction, in lieu of the shares
of Common Stock (or other securities, cash, assets or other property) issuable upon the exercise of the Warrant prior to such Fundamental
Transaction, such shares of stock, securities, cash, assets or any other property whatsoever (including warrants or other subscription
rights) which the Holder would have been entitled to receive upon the happening of such Fundamental Transaction had this Warrant
been exercised in full immediately prior to such Fundamental Transaction, as adjusted in accordance with the provisions of this
Warrant. In addition to and not in substitution for any other rights hereunder (but without duplication of the foregoing provisions
of this paragraph), prior to the consummation of any Fundamental Transaction pursuant to which holders of shares of Common Stock
are entitled to receive securities or other assets with respect to or in exchange for shares of Common Stock (a “Corporate
Event”), the Company shall make appropriate provision to ensure that the Holder will thereafter have the right to receive
upon an exercise of this Warrant at any time after the consummation of the Corporate Event but prior to the Expiration Date, in
lieu of shares of Common Stock (or other securities, cash, assets or other property) purchasable upon the exercise of this Warrant
prior to such Corporate Event, such shares of stock, securities, cash, assets or any other property whatsoever (including warrants
or other purchase or subscription rights) which the Holder would have been entitled to receive upon the happening of such Corporate
Event had this Warrant been exercised in full immediately prior to such Corporate Event. Provision made pursuant to the preceding
sentence shall be in a form and substance reasonably satisfactory to the Required Holders. The provisions of this Section 4(b)
shall apply similarly and equally to successive Fundamental Transactions and Corporate Events and shall be applied without regard
to any limitations on the exercise of this Warrant.

 

(c) Warrant
Purchase. Notwithstanding the foregoing and the provisions of Section 4(b) above, in the event of the consummation
of a Fundamental Transaction that is (1) an all-cash transaction, (2) a “Rule 13e-3 transaction” as defined
in Rule 13e-3 under the Exchange Act or (3) a Fundamental Transaction involving a Person not traded on an Eligible Market,
at the request of the Holder delivered at any time commencing on the earliest to occur of (x) the public disclosure of the Fundamental
Transaction or (y) the consummation of the Fundamental Transaction, through the date that is ninety (90) days after the public
disclosure of the consummation of such Fundamental Transaction by the Company pursuant to a Current Report on Form 8-K filed
with the Securities and Exchange Commission, the Company or the Successor Entity (as the case may be) shall purchase this Warrant
from the Holder on the later of (i) the date of consummation of the Fundamental Transaction and (ii) the fifth Trading
Day following the date of such request, in each case by paying to the Holder cash in an amount equal to the fair market value (as
mutually determined by the Company and the Holder) of the consideration that would have been payable in such Fundamental Transaction
in respect of the shares of Common Stock (or other securities, cash, assets or other property) purchasable upon the exercise of
this Warrant had this Warrant been exercised in full immediately prior to such Fundamental Transaction, less the aggregate Exercise
Price applicable thereto.

 

    	10

    	 

    

 

(d) Applicability
to Successive Transactions. The provisions of this Section shall apply similarly and equally to successive Fundamental Transactions
and Corporate Events and shall be applied without regard to any limitations on the exercise of this Warrant.

 

5.  NONCIRCUMVENTION.
The Company hereby covenants and agrees that the Company will not, by amendment of its Certificate of Incorporation, Bylaws or
through any reorganization, transfer of assets, consolidation, merger, scheme of arrangement, dissolution, issue or sale of securities,
or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, and will
at all times in good faith comply with all the provisions of this Warrant and take all actions consistent with effectuating the
purposes of this Warrant. Without limiting the generality of the foregoing, the Company (i) shall not increase the par value
of any shares of Common Stock receivable upon the exercise of this Warrant above the Exercise Price then in effect, (ii) shall
take all such actions as may be necessary or appropriate in order that the Company may validly and legally issue fully paid and
nonassessable shares of Common Stock upon the exercise of this Warrant, and (iii) shall, so long as this Warrant is outstanding,
take all action necessary to reserve and keep available out of its authorized and unissued shares of Common Stock, solely for the
purpose of effecting the exercise of this Warrant, 100% of the number of shares of Common Stock issuable upon exercise of this
Warrant then outstanding (without regard to any limitations on exercise).

 

6.  WARRANT
HOLDER NOT DEEMED A STOCKHOLDER. Except as otherwise specifically provided herein, the Holder, solely in such Person’s
capacity as a holder of this Warrant, shall not be entitled to vote or receive dividends or be deemed the holder of share capital
of the Company for any purpose, nor shall anything contained in this Warrant be construed to confer upon the Holder, solely in
such Person’s capacity as the Holder of this Warrant, any of the rights of a stockholder of the Company or any right to vote,
give or withhold consent to any corporate action (whether any reorganization, issue of stock, reclassification of stock, consolidation,
merger, conveyance or otherwise), receive notice of meetings, receive dividends or subscription rights, or otherwise, prior to
the issuance to the Holder of the Warrant Shares which such Person is then entitled to receive upon the due exercise of this Warrant.
In addition, nothing contained in this Warrant shall be construed as imposing any liabilities on the Holder to purchase any securities
(upon exercise of this Warrant or otherwise) or as a stockholder of the Company, whether such liabilities are asserted by the Company,
creditors of the Company or any other Person.

 

    	11

    	 

    

 

		7.	REISSUANCE OF WARRANTS.

 

(a) Transfer
of Warrant. If this Warrant is to be transferred, the Holder shall surrender this Warrant to the Company and deliver the completed
and executed Assignment Form, in the form attached hereto as Exhibit B, whereupon the Company will forthwith issue
and deliver upon the order of the Holder a new Warrant (in accordance with Section 7(d)), registered as the Holder
may request, representing the right to purchase the number of Warrant Shares being transferred by the Holder and, if less then
the total number of Warrant Shares then underlying this Warrant is being transferred, a new Warrant (in accordance with Section 7(d))
to the Holder representing the right to purchase the number of Warrant Shares not being so transferred.

 

(b) Lost, Stolen
or Mutilated Warrant. Upon receipt by the Company of evidence reasonably satisfactory to the Company of the loss, theft, destruction
or mutilation of this Warrant, and, in the case of loss, theft or destruction, of any indemnification undertaking by the Holder
to the Company in reasonable and customary form and, in the case of mutilation, upon surrender and cancellation of this Warrant,
the Company shall execute and deliver to the Holder a new Warrant (in accordance with Section 7(d)) representing the
right to purchase the Warrant Shares then underlying this Warrant.

 

(c) Exchangeable
for Multiple Warrants. This Warrant is exchangeable, upon the surrender hereof by the Holder at the principal office of the
Company, for a new Warrant or Warrants (in accordance with Section 7(d)), representing in the aggregate the right to
purchase the number of Warrant Shares then underlying this Warrant, and each such new Warrant will represent the right to purchase
such portion of such Warrant Shares as is designated by the Holder at the time of such surrender.

 

(d) Issuance
of New Warrants. Whenever the Company is required to issue a new Warrant pursuant to the terms of this Warrant, such new Warrant
(i) shall be of like tenor with this Warrant, (ii) shall represent, as indicated on the face of such new Warrant, the right to
purchase the Warrant Shares then underlying this Warrant (or in the case of a new Warrant being issued pursuant to Section 7(a)
or Section 7(c), the Warrant Shares designated by the Holder which, when added to the number of shares of Common Stock
underlying the other new Warrants issued in connection with such issuance, does not exceed the number of Warrant Shares then underlying
this Warrant), (iii) shall have an issuance date, as indicated on the face of such new Warrant which is the same as the Issuance
Date, and (iv) shall have the same rights and conditions as this Warrant.

 

    	12

    	 

    

 

8.  NOTICES.
All notices and other communications given or made pursuant to this Agreement shall be in writing and shall be deemed effectively
given upon the earlier of actual receipt or: (i) personal delivery to the party to be notified; (ii) when sent, if sent
by facsimile during the recipient’s normal business hours, and if not sent during normal business hours, then on the recipient’s
next business day; (iii) five (5) days after having been sent by registered or certified mail, return receipt requested, postage
prepaid; or (iv) one (1) business day after the business day of deposit with a nationally recognized overnight courier, freight
prepaid, specifying next-day delivery, with written verification of receipt. All such notices and communications shall be sent
to the Company at its address set forth under its name on the signature pages hereto and to the Holder at its address as set forth
in the books and records of the Company, or to such other facsimile number or address as subsequently modified by written notice
given in accordance with this Section 8. The Company shall provide the Holder with prompt written notice of all actions
taken pursuant to this Warrant, including in reasonable detail a description of such action and the reason therefor. Without limiting
the generality of the foregoing, the Company will give written notice to the Holder (i) promptly after any adjustment of the
Exercise Price or the number of Warrant Shares, setting forth in reasonable detail, and certifying, the calculation of such adjustment
and (ii) at least ten (10) days prior to the date on which the Company closes its books or takes a record (A) with respect
to any dividend or distribution to holders of shares of Common Stock, (B) with respect to any grants, issuances or sales of
any Options, Convertible Securities or rights to purchase stock, warrants, securities or other property to holders of shares of
Common Stock generally or (C) for determining rights to vote with respect to any Fundamental Transaction, dissolution or liquidation,
provided in each case that such information shall be made known to the public prior to or in conjunction with such notice
being provided to the Holder.

 

9.  AMENDMENT
AND WAIVER. Except as otherwise provided herein, the provisions of this Warrant may be amended and the Company may take any
action herein prohibited, or omit to perform any act herein required to be performed by it, only if the Company has obtained the
prior written consent of the Required Holders; provided, however, that no amendment or waiver that would (i) increase
the Exercise Price of any Warrants or reduce the number of Warrant Shares issuable upon the exercise of any Warrants, (ii) change
or waive the right to exercise any Warrants or change the Expiration Date or (iii) change or waive any of the provisions of
this Section 9 or with respect to the requisite percentage of holders of Warrants required to consent to or take any
action, shall be effective as to any holder of Warrants without the prior written consent of such holder.

 

10. GOVERNING
LAW; CONSENT TO JURISDICTION; WAIVER OF JURY TRIAL. This Warrant shall be governed by, and construed and enforced in accordance
with, the laws of the State of New York. The Company and, by accepting this Warrant, the Holder, each irrevocably submits to the
exclusive jurisdiction of the courts of the State of New York located in New York County and the United States District Court for
the Southern District of New York for the purpose of any suit, action, proceeding or judgment relating to or arising out of this
Warrant and the transactions contemplated hereby. Service of process in connection with any such suit, action or proceeding may
be served on each party hereto anywhere in the world by the same methods as are specified for the giving of notices under this
Warrant. The Company and, by accepting this Warrant, the Holder, each irrevocably consents to the jurisdiction of any such court
in any such suit, action or proceeding and to the laying of venue in such court. The Company and, by accepting this Warrant, the
Holder, each irrevocably waives any objection to the laying of venue of any such suit, action or proceeding brought in such courts
and irrevocably waives any claim that any such suit, action or proceeding brought in any such court has been brought in an inconvenient
forum. EACH OF THE COMPANY AND, BY ITS ACCEPTANCE HEREOF, THE HOLDER WAIVES ANY RIGHT TO REQUEST A TRIAL BY JURY IN ANY LITIGATION
WITH RESPECT TO THIS WARRANT AND REPRESENTS THAT COUNSEL HAS BEEN CONSULTED SPECIFICALLY AS TO THIS WAIVER.

 

    	13

    	 

    

 

11. CONSTRUCTION;
HEADINGS. This Warrant shall be deemed to be jointly drafted by the Company and the Holder and shall not be construed against
any Person as the drafter hereof. The headings of this Warrant are for convenience of reference and shall not form part of, or
affect the interpretation of, this Warrant.

 

12. DISPUTE RESOLUTION.
In the case of a dispute as to the determination of the Exercise Price or the arithmetic calculation of the Warrant Shares, the
Company shall submit the disputed determinations or arithmetic calculations via facsimile within two (2) Business Days of receipt
of the Exercise Notice giving rise to such dispute, as the case may be, to the Holder. If the Holder and the Company are unable
to agree upon such determination or calculation of the Exercise Price or the Warrant Shares within three (3) Business Days of such
disputed determination or arithmetic calculation being submitted to the Holder, then the Company shall, within two (2) Business
Days submit via facsimile (a) the disputed determination of the Exercise Price to an independent, reputable investment bank selected
by the Company and approved by the Holder or (b) the disputed arithmetic calculation of the Warrant Shares to the Company’s
independent, outside accountant. The Company shall cause the investment bank or the accountant, as the case may be, to perform
the determinations or calculations and notify the Company and the Holder of the results no later than ten (10) Business Days from
the time it receives the disputed determinations or calculations. The prevailing party in any dispute resolved pursuant to this
Section 12 shall be entitled to the full amount of all reasonable expenses, including all costs and fees paid or incurred
in good faith, in relation to the resolution of such dispute. Such investment bank’s or accountant’s determination
or calculation, as the case may be, shall be binding upon all parties absent demonstrable error.

 

13.     REMEDIES,
OTHER OBLIGATIONS, BREACHES AND INJUNCTIVE RELIEF. The remedies provided in this Warrant shall be cumulative and in addition
to all other remedies available under this Warrant, at law or in equity (including a decree of specific performance and/or other
injunctive relief), and nothing herein shall limit the right of the Holder to pursue actual damages for any failure by the Company
to comply with the terms of this Warrant. The Company acknowledges that a breach by it of its obligations hereunder will cause
irreparable harm to the Holder and that the remedy at law for any such breach may be inadequate. The Company therefore agrees that,
in the event of any such breach or threatened breach, the holder of this Warrant shall be entitled, in addition to all other available
remedies, to an injunction restraining any breach, without the necessity of showing economic loss and without any bond or other
security being required.

 

14. TRANSFER.
Subject to applicable laws, this Warrant may be offered for sale, sold, transferred or assigned without the consent of the Company.

 

15. SEVERABILITY.
If any provision of this Warrant or the application thereof becomes or is declared by a court of competent jurisdiction to be illegal,
void or unenforceable, the remainder of the terms of this Warrant will continue in full force and effect.

 

    	14

    	 

    

 

16. CERTAIN DEFINITIONS.
For purposes of this Warrant, the following terms shall have the following meanings:

 

(a) “Approved
Stock Plan” means any employee benefit plan or other issuance, employment agreement or option grant or similar agreement
which has been approved by the Board of Directors of the Company, pursuant to which the Company’s securities may be issued
to any employee, consultant, officer or director for services provided to the Company.

 

(b) “Bloomberg”
means Bloomberg Financial Markets.

 

(c) “Business
Day” means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized
or required by law to remain closed.

 

(d) “Closing
Bid Price” and “Closing Sale Price” means, for any security as of any date, the last closing bid price
and last closing trade price, respectively, for such security on the Principal Market, as reported by Bloomberg, or, if the Principal
Market begins to operate on an extended hours basis and does not designate the closing bid price or the closing trade price, as
the case may be, then the last bid price or the last trade price, respectively, of such security prior to 4:00:00 p.m., New York
time, as reported by Bloomberg, or, if the Principal Market is not the principal securities exchange or trading market for such
security, the last closing bid price or last trade price, respectively, of such security on the principal securities exchange or
trading market where such security is listed or traded as reported by Bloomberg, or if the foregoing do not apply, the last closing
bid price or last trade price, respectively, of such security in the over-the-counter market on the electronic bulletin board for
such security as reported by Bloomberg, or, if no closing bid price or last trade price, respectively, is reported for such security
by Bloomberg, the average of the bid prices, or the ask prices, respectively, of any market makers for such security as reported
in the “pink sheets” by Pink Sheets LLC (formerly the National Quotation Bureau, Inc.). If the Closing Bid Price or
the Closing Sale Price cannot be calculated for a security on a particular date on any of the foregoing bases, the Closing Bid
Price or the Closing Sale Price, as the case may be, of such security on such date shall be the fair market value of such security,
as mutually determined by the Company and the Holder. All such determinations to be appropriately adjusted for any stock dividend,
stock split, stock combination or other similar transaction during the applicable calculation period.

 

(e) “Common
Stock” means (i) the Company’s shares of Common Stock, par value $0.01 per share and (ii) any share capital
into which such Common Stock shall have been changed or any share capital resulting from a reclassification of such Common Stock.

 

(f) “Convertible
Securities” means any stock or securities (other than Options) directly or indirectly convertible into or exercisable
or exchangeable for shares of Common Stock.

 

(g) “Eligible
Market” means the Principal Market, The New York Stock Exchange, Inc., The NYSE Amex, The NASDAQ Capital Market or The
NASDAQ Global Select Market.

 

    	15

    	 

    

 

(h) “Exchange
Act” means the Securities Exchange Act of 1934, as amended.

 

(i) “Expiration
Date” means the fifth (5th) anniversary of the Issuance Date or, if such date falls on a day other than a
Trading Day or on which trading does not take place on the Principal Market or, if the Principal Market is not the principal trading
market for the Common Stock, then on the principal securities exchange or securities market on which the Common Stock is then traded
(a “Holiday”), the next date that is not a Holiday.

 

(j) “Excluded
Securities” means: (i) up to 500,000 shares of Common Stock, including Options and Convertible Securities therefor
(appropriately adjusted for any stock split, reverse stock split, stock dividend or other reclassification or combination of the
Common Stock occurring after the Subscription Date) issued to directors, officers, employees or consultants of the Company in connection
with their service as directors of the Company, their employment by the Company or their retention as consultants by the Company
pursuant to an Approved Stock Plan; (ii) securities issued pursuant to the Financing Agreement and securities issued upon
the exercise or conversion of those securities; and (iii) shares of Common Stock issued or issuable by reason of a dividend,
stock split or other distribution on shares of Common Stock (but only to the extent that such a dividend, split or distribution
results in an adjustment in the number of Warrant Shares pursuant to the other provisions of this Warrant).

 

(k) “Fundamental
Transaction” means that the Company shall, directly or indirectly, in one or more related transactions, (i) consolidate
or merge with or into (whether or not the Company is the surviving corporation) another Person (but excluding a migratory merger
effected solely for the purpose of changing the jurisdiction of incorporation of the Company), (ii) sell, assign, transfer,
convey or otherwise dispose of all or substantially all of the properties or assets of the Company to another Person, (iii) become
subject to or agree to allow another Person(s) to make a purchase, tender or exchange offer that is accepted by the holders of
more than the 50% of the outstanding shares of Common Stock (not including any shares of Common Stock held by the Person or Persons
making or party to, or associated or affiliated with the Person(s) making or party to, such purchase, tender or exchange offer),
(iv) consummate a stock purchase agreement or other business combination (including, without limitation, a reorganization,
recapitalization, spin-off or scheme of arrangement) with another Person(s) whereby such other Person(s) acquires more than 50%
of the outstanding shares of Common Stock (not including any shares of Common Stock held by the other Person or Persons making
or party to, or associated or affiliated with the other Person(s) making or party to, such stock purchase agreement or other business
combination), (v) reorganize, recapitalize or reclassify its Common Stock or (vi) any “person” or “group”
(as these terms are used for purposes of Sections 13(d) and 14(d) of the Exchange Act) is or shall become the “beneficial
owner” (as defined in Rule 13d-3 under the Exchange Act), directly or indirectly, of 50% of the aggregate ordinary voting
power represented by the issued and outstanding shares of Common Stock.

 

(l) “Investor
Rights Agreement” means the Investor Rights Agreement dated as of the Subscription Date between the Company
and the investor(s) party thereto, as it may be amended, restated, supplemented or otherwise modified from time to time.

 

    	16

    	 

    

 

(m) “Options”
means any rights, warrants or options to subscribe for or purchase shares of Common Stock or Convertible Securities.

 

(n) “Parent
Entity” of a Person means an entity that, directly or indirectly, controls the applicable Person and whose common stock
or equivalent equity security is quoted or listed on an Eligible Market or, if there is more than one such Person or Parent Entity,
the Person or Parent Entity with the largest public market capitalization as of the date of consummation of the Fundamental Transaction.

 

(o) “Person”
means an individual, a limited liability company, a partnership, a joint venture, a corporation, a trust, an unincorporated organization,
any other entity and a government or any department or agency thereof.

 

(p) “Principal
Market” means The NASDAQ Global Market.

 

(q) “Reference
Price” means $5.00 (appropriately adjusted for any stock split, reverse stock split, stock dividend or other reclassification
or combination of the Common Stock occurring after the Subscription Date) per share of Common Stock.

 

(r) “Registration
Rights Agreement” means the Registration Rights Agreement dated as of the Subscription Date between the Company
and the investor(s) party thereto, as it may be amended, restated, supplemented or otherwise modified from time to time.

 

(s) “Required
Holders” means, as of any date, the holders of Warrants representing at least a majority of the shares of Common Stock
underlying the Warrants outstanding as of such date.

 

(t) “Securities
Act” means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.

 

(u) “Successor
Entity” means the Person (or, if so elected by the Holder, the Parent Entity) formed by, resulting from or surviving
any Fundamental Transaction or the Person (or, if so elected by the Holder, the Parent Entity) with which such Fundamental Transaction
shall have been entered into.

 

(v) “Trading
Day” means any day on which the shares of Common Stock are traded on the Principal Market or, if the Principal Market
is not the principal trading market for the Common Stock, then on the principal securities exchange or securities market on which
the Common Stock are then traded; provided that “Trading Day” shall not include any day on which the Common
Stock are scheduled to trade on such exchange or market for less than 4.5 hours or any day that the Common Stock are suspended
from trading during the final hour of trading on such exchange or market (or if such exchange or market does not designate in advance
the closing time of trading on such exchange or market, then during the hour ending at 4:00:00 p.m., New York time).

 

    	17

    	 

    

 

(w) “Transaction
Documents” means the Financing Agreement, any notes issued thereunder, any guarantees and security documents entered
into in connection therewith, the Warrants, the Registration Rights Agreement, the Investor Rights Agreement, and any other agreement,
instrument or other document executed and/or delivered from time to time in connection therewith, and including all amendments,
restatements, supplements or other modifications thereof.

 

(x) “Weighted
Average Price” means, for any security as of any date, the dollar volume-weighted average price for such security on
the Principal Market during the period beginning at 9:30:01 a.m., New York time (or such other time as the Principal Market publicly
announces is the official open of trading), and ending at 4:00:00 p.m., New York time (or such other time as the Principal Market
publicly announces is the official close of trading), as reported by Bloomberg through its “Volume at Price” function
or, if the foregoing does not apply, the dollar volume-weighted average price of such security in the over-the-counter market on
the electronic bulletin board for such security during the period beginning at 9:30:01 a.m., New York time (or such other time
as the Principal Market publicly announces is the official open of trading), and ending at 4:00:00 p.m., New York time (or such
other time as the Principal Market publicly announces is the official close of trading), as reported by Bloomberg, or, if no dollar
volume-weighted average price is reported for such security by Bloomberg for such hours, the average of the highest closing bid
price and the lowest closing ask price of any of the market makers for such security as reported in the “pink sheets”
by OTC Markets LLC. If the Weighted Average Price cannot be calculated for a security on a particular date on any of the foregoing
bases, the Weighted Average Price of such security on such date shall be the fair market value as mutually determined by the Company
and the Holder. If the Company and the Holder are unable to agree upon the fair market value of such security, then such dispute
shall be resolved pursuant to Section 12 with the term “Weighted Average Price” being substituted for the
term “Exercise Price.” All such determinations shall be appropriately adjusted for any stock dividend, stock split,
stock combination or other similar transaction during the applicable calculation period.

 

[Signature Page Follows]

 

    	18

    	 

    

 

IN WITNESS WHEREOF,
the Company has caused this Warrant to Purchase Common Stock to be duly executed as of the Issuance Date set out above.

 

	 	lAKELAND iNDUSTRIES, iNC.
	 	 
	 	By: 	/s/ Christopher J. Ryan
	 	Name: Christopher J. Ryan
	 	Title: President and Chief Executive Officer

 

	 	Address:	701-7 Koehler Avenue
	 	 	Ronkonkoma, NY 11779
	 	Attention:	Gary Pokrossa
	 	Facsimile:	(631) 981-9751

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00218-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00218-of-00352.parquet"}]]